NCT06396104

Brief Summary

Mobilisation with movement (Mulligan Sustained Natural Apophyseal Glides (SNAG)). method has been shown to have significant effects on pain, joint range of motion, and functionality in patients with neck pain. However, there is a lack of studies examining the effects of this technique on muscle stiffness associated with neck pain. Considering the immediate effects of a single session of lumbar SNAG application on lumbar muscle stiffness in patients with low back pain, it raises curiosity about the effects it would have on cervical spinal segments and surrounding muscles. The aim of this study is to investigate the immediate effects of Mulligan SNAG application on muscle stiffness, pain, and joint range of motion in patients with mechanical neck pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 24, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 2, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2024

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

July 8, 2024

Status Verified

April 1, 2024

Enrollment Period

5 months

First QC Date

April 24, 2024

Last Update Submit

July 4, 2024

Conditions

Keywords

Neck PainManual TherapySham Treatment

Outcome Measures

Primary Outcomes (1)

  • Muscle stiffness

    Muscle stiffness will be measured with MyotonPRO (Myoton SA, Tallinn, Estonia). A brief mechanical pulse is applied to the skin over the muscle and then quickly released. Stiffness (N/m) is a parameter related to the capacity to withstand an external force. The reliability of the device has been proven in healthy individuals.The measurement site will be marked on the skin with a pen. In all applications, MyotonPRO's probe will be placed perpendicular to the skin and 3 measurements will be recorded using the multi-scanning mode with 10 pulses 1 second apart, and the average of the 3 measurements will be used for analysis. Upper trapezius: Evaluation will be performed in prone position. Measurements are from the midpoint between the lateral edge of the acromion and the spinous process of C7. Sternocleidomastoid: Measurements will be made at the midpoint between the sternum and the mastoid protrusion, with individuals lying in a supine position with a soft pillow under the neck.

    Baseline and immediately after application.

Secondary Outcomes (3)

  • Joint Range of Motion

    Baseline and immediately after application.

  • Numeric Pain Rating Scale

    Baseline and immediately after application.

  • Neck Disability Index

    Baseline

Study Arms (2)

Mobilization with movement group

EXPERIMENTAL
Other: Mobilisation with movement

Sham group

SHAM COMPARATOR
Other: Sham mobilisation

Interventions

The physiotherapist places the medial edge of the thumb of one hand on the upper facet joint of the relevant segment, then applies superior-anterior slide to the facet joint by providing support with the thumb of the other hand. The 'gliding' movement is maintained while the patient actively performs the unilateral neck rotation movement and maintains it for a few seconds at the end of the movement. If joint movement is painful, attempts are made on the other facet joint of the same segment or on the spinous process. If this attempt does not immediately improve the patient's active joint motion, Mulligan Sustained Natural Apophyseal Glides (SNAG) will be applied to the upper part of the left zygapophysial joint, and in case of failure again, application will be made through the superior spinous process of the relevant segment. Painless joint movement will be applied in 6 repetitions and 3 sets.

Mobilization with movement group

While the patients are sitting in a chair with a supported back, the spinal segment where pain is felt in neck joint movements will be determined. Without applying a sliding movement to this segment over the facet joint, only sensory input will be given and the patient will be asked to continue the active rotation movement and wait a few seconds at the end of the movement. The application will be completed as 6 repetitions and 3 sets.

Sham group

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Having widespread neck pain lasting more than 3 months
  • Pain symptoms that increase with neck movements or palpation
  • Volunteering to participate in the study

You may not qualify if:

  • History of neck trauma
  • Previous cervical surgery
  • Cervical radiculopathy or myelopathy
  • Fibromyalgia syndrome diagnosis
  • Any physiotherapy intervention in the previous 12 months
  • Sign of vertebrobasilar insufficiency
  • Upper cervical spine ligament instability
  • Those using steroids or muscle relaxants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Kent University

Istanbul, 34320, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Neck Pain

Interventions

Movement

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Physiological PhenomenaMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The physiotherapist who will apply the evaluation methods to be used in our study will be blind to the group distribution of the patients. Additionally, patients will be blind to the procedure.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A Parallel, double blind, randomised controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 24, 2024

First Posted

May 2, 2024

Study Start

January 10, 2024

Primary Completion

June 15, 2024

Study Completion

June 30, 2024

Last Updated

July 8, 2024

Record last verified: 2024-04

Locations